Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
SWK Holdings Corp | Director | Common Stock | 6.18K | $111K | $17.95 | Dec 30, 2022 | Direct |
EyePoint Pharmaceuticals, Inc. | Director | Common Stock | 9.97K | $77.6K | $7.79 | Aug 20, 2024 | Direct |
Akari Therapeutics Plc | Interim CFO | Ordinary Shares, par value $0.0001 per share | 158M | May 1, 2024 | Direct | ||
EyePoint Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 25K | Jan 5, 2024 | Direct | ||
Renovacor, Inc. | Chief Financial Officer | Common Stock | 0 | $8.00 | Dec 1, 2022 | Direct | |
Renovacor, Inc. | Chief Financial Officer | Stock Option | 0 | Dec 1, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
EYPT | EyePoint Pharmaceuticals, Inc. | Aug 20, 2024 | 1 | $20K | 4 | Aug 21, 2024 | Director |
AKTX | Akari Therapeutics Plc | May 1, 2024 | 1 | $0 | 4 | May 3, 2024 | Interim CFO |
EYPT | EyePoint Pharmaceuticals, Inc. | Jan 5, 2024 | 1 | $0 | 4 | Jan 9, 2024 | Director |
AKTX | Akari Therapeutics Plc | Jan 1, 2024 | 0 | $0 | 3 | Jan 2, 2024 | Interim CFO |
EYPT | EyePoint Pharmaceuticals, Inc. | Jun 20, 2023 | 2 | $0 | 4 | Jun 22, 2023 | Director |
EYPT | EyePoint Pharmaceuticals, Inc. | Feb 9, 2023 | 2 | $0 | 4 | Feb 13, 2023 | Director |
SWKH | SWK Holdings Corp | Dec 30, 2022 | 2 | $33.5K | 4 | Jan 4, 2023 | Director |
RCOR | Renovacor, Inc. | Dec 1, 2022 | 7 | $0 | 4 | Dec 5, 2022 | Chief Financial Officer |
SWKH | SWK Holdings Corp | Sep 30, 2022 | 2 | $33.5K | 4 | Oct 4, 2022 | Director |
SWKH | SWK Holdings Corp | Jun 30, 2022 | 1 | $19.9K | 4 | Jul 5, 2022 | Director |
RCOR | Renovacor, Inc. | Jun 17, 2022 | 1 | $0 | 4 | Jun 21, 2022 | Chief Financial Officer |
RCOR | Renovacor, Inc. | Jun 17, 2022 | 0 | $0 | 3 | Jun 21, 2022 | Chief Financial Officer |
SWKH | SWK Holdings Corp | Mar 31, 2022 | 1 | $19.8K | 4 | Apr 4, 2022 | Director |
SWKH | SWK Holdings Corp | Feb 15, 2022 | 0 | $0 | 3 | Feb 22, 2022 | Director |
EYPT | EyePoint Pharmaceuticals, Inc. | Feb 9, 2022 | 4 | $0 | 4 | Feb 11, 2022 | Director |
RCOR | Renovacor, Inc. | Jan 24, 2022 | 2 | $0 | 4 | Jan 26, 2022 | Interim CFO |
RCOR | Renovacor, Inc. | Sep 3, 2021 | 1 | $0 | 4 | Sep 8, 2021 | Interim CFO |
RCOR | Renovacor, Inc. | Sep 2, 2021 | 0 | $0 | 3 | Sep 7, 2021 | Interim CFO |
EYPT | EyePoint Pharmaceuticals, Inc. | Jun 22, 2021 | 2 | $0 | 4 | Jun 23, 2021 | Director |